The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
<iframe src="https://statesidedaily.com/embed/cluster/8487b66ad4124351d3211f235c2b694058ec72a6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA advisers vote against sleep peptide as they debate safety and health claims"></iframe>
